| Dr William Bruce Sanderson, MD | |
|
1415 E Kincaid St, Mount Vernon, WA 98274-4126 | |
| (360) 424-4111 | |
| Not Available |
| Full Name | Dr William Bruce Sanderson |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 12 Years |
| Location | 1415 E Kincaid St, Mount Vernon, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568720043 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 48329 (Kentucky) | Secondary |
| 207P00000X | Emergency Medicine | MD60733144 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Joseph Hospital | Bellingham, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northwest Emergency Physicians Llc | 3476462334 | 186 |
News Archive
InnerWorkings, Inc., a leading global marketing supply chain company, and Easter Seals, the leading nonprofit provider of services for individuals with autism, developmental disabilities, physical and mental disabilities and other special needs, today announced a new multi-year fundraising-focused procurement partnership. Under the agreement, InnerWorkings will manage the printing and logistics of Easter Seals' fundraising materials.
A patent describing the use of 'microbiota replacement therapy' was filed as a joint venture between King's and University College London's Institute of Child Health last month.
Managing type 1 diabetes is a never-ending task that requires multiple blood glucose tests, carbohydrate calculations and insulin injections or infusions. This constant effort to control the disease is daunting at any age - and it's especially challenging for teens and young adults.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that the U.S. Food and Drug Administration has assigned a Prescription Drug User Fee Act (PDUFA) action date of January 31, 2011 for the review of the Contrave® (naltrexone sustained release (SR)/bupropion SR) New Drug Application (NDA).
Now, a team of international scientists, including 239 health experts from 32 countries, has written an open letter to the WHO urging the organization to revise its recommendations for the spread of SARS-CoV-2, due to mounting evidence that the disease is airborne for more extended periods than the WHO advisory.
› Verified 5 days ago
| Entity Name | Northwest Emergency Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235172370 PECOS PAC ID: 3476462334 Enrollment ID: O20041214000892 |
News Archive
InnerWorkings, Inc., a leading global marketing supply chain company, and Easter Seals, the leading nonprofit provider of services for individuals with autism, developmental disabilities, physical and mental disabilities and other special needs, today announced a new multi-year fundraising-focused procurement partnership. Under the agreement, InnerWorkings will manage the printing and logistics of Easter Seals' fundraising materials.
A patent describing the use of 'microbiota replacement therapy' was filed as a joint venture between King's and University College London's Institute of Child Health last month.
Managing type 1 diabetes is a never-ending task that requires multiple blood glucose tests, carbohydrate calculations and insulin injections or infusions. This constant effort to control the disease is daunting at any age - and it's especially challenging for teens and young adults.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that the U.S. Food and Drug Administration has assigned a Prescription Drug User Fee Act (PDUFA) action date of January 31, 2011 for the review of the Contrave® (naltrexone sustained release (SR)/bupropion SR) New Drug Application (NDA).
Now, a team of international scientists, including 239 health experts from 32 countries, has written an open letter to the WHO urging the organization to revise its recommendations for the spread of SARS-CoV-2, due to mounting evidence that the disease is airborne for more extended periods than the WHO advisory.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr William Bruce Sanderson, MD 1415 E Kincaid St, Mount Vernon, WA 98274-4126 Ph: (360) 424-4111 | Dr William Bruce Sanderson, MD 1415 E Kincaid St, Mount Vernon, WA 98274-4126 Ph: (360) 424-4111 |
News Archive
InnerWorkings, Inc., a leading global marketing supply chain company, and Easter Seals, the leading nonprofit provider of services for individuals with autism, developmental disabilities, physical and mental disabilities and other special needs, today announced a new multi-year fundraising-focused procurement partnership. Under the agreement, InnerWorkings will manage the printing and logistics of Easter Seals' fundraising materials.
A patent describing the use of 'microbiota replacement therapy' was filed as a joint venture between King's and University College London's Institute of Child Health last month.
Managing type 1 diabetes is a never-ending task that requires multiple blood glucose tests, carbohydrate calculations and insulin injections or infusions. This constant effort to control the disease is daunting at any age - and it's especially challenging for teens and young adults.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that the U.S. Food and Drug Administration has assigned a Prescription Drug User Fee Act (PDUFA) action date of January 31, 2011 for the review of the Contrave® (naltrexone sustained release (SR)/bupropion SR) New Drug Application (NDA).
Now, a team of international scientists, including 239 health experts from 32 countries, has written an open letter to the WHO urging the organization to revise its recommendations for the spread of SARS-CoV-2, due to mounting evidence that the disease is airborne for more extended periods than the WHO advisory.
› Verified 5 days ago
Sarah Mcdaniel, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 Hospital Pkwy, Mount Vernon, WA 98273 Phone: 360-428-2166 | |
Dr. Michael Matthews Chmel, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1415 E Kincaid St, Mount Vernon, WA 98274 Phone: 360-424-4111 | |
Dr. Michael K Olpin, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1415 E Kincaid St, Mount Vernon, WA 98274 Phone: 360-424-4111 | |
Anne L Saarheim-riggs, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1400 E. Kincaid Street, Mount Vernon, WA 98274 Phone: 360-428-2500 Fax: 360-428-6485 | |
Dr. Kevin Roy Bowman, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1415 E Kincaid St, Mount Vernon, WA 98274 Phone: 360-424-4111 | |
Dr. Marsha Janette Tomlinson, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1415 E. Kincaid Street, Mount Vernon, WA 98274 Phone: 360-424-4111 | |
Dr. Tara L. Montgomery, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1400 E. Kincaid Street, Mount Vernon, WA 98274 Phone: 360-428-6434 Fax: 360-848-4233 |